Suppr超能文献

聚焦 COVID-19:十八个月过去了。

Spotlight on COVID-19: eighteen months on.

机构信息

Laboratory of Cardiovascular Biology, The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

Laboratory of Molecular Virology, The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

出版信息

FEBS J. 2021 Sep;288(17):4992-4995. doi: 10.1111/febs.16167.

Abstract

In this Editorial, we highlight the contents of The FEBS Journal's second Special Issue focussed on COVID-19. The issue covers a variety of aspects related to COVID-19, ranging from the most recent improvements in therapies and the significant impact of rapidly developed COVID-19 vaccines to the emergence of variants of SARS-CoV-2, the role of the immune system in the various stages of the disease and the impact of the disease in different organs. We hope that this collection of articles will give readers an informative and critical perspective on recent advances in understanding and treating COVID-19.

摘要

在这篇社论中,我们重点介绍 FEBS 期刊第二期聚焦 COVID-19 的特刊的内容。该特刊涵盖了与 COVID-19 相关的各种方面,从治疗方法的最新进展和快速开发的 COVID-19 疫苗的重大影响,到 SARS-CoV-2 变体的出现,免疫系统在疾病各个阶段的作用以及该疾病对不同器官的影响。我们希望这组文章能为读者提供有关理解和治疗 COVID-19 方面的最新进展的信息和批判性视角。

相似文献

1
Spotlight on COVID-19: eighteen months on.
FEBS J. 2021 Sep;288(17):4992-4995. doi: 10.1111/febs.16167.
2
The impact of SARS-CoV-2 variants on IBD management.
Lancet Gastroenterol Hepatol. 2021 May;6(5):343-344. doi: 10.1016/S2468-1253(21)00075-3. Epub 2021 Mar 10.
3
Spotlight on COVID-19: from biology to therapy and prevention.
FEBS J. 2020 Sep;287(17):3606-3608. doi: 10.1111/febs.15530.
4
Public opinion on global rollout of COVID-19 vaccines.
Nat Med. 2021 Jun;27(6):935-936. doi: 10.1038/s41591-021-01322-9.
5
South Africa responds to new SARS-CoV-2 variant.
Lancet. 2021 Jan 23;397(10271):267. doi: 10.1016/S0140-6736(21)00144-6.
6
Cancer and COVID-19 vaccines: a complex global picture.
Lancet Oncol. 2021 Jun;22(6):749-751. doi: 10.1016/S1470-2045(21)00244-8. Epub 2021 Apr 27.
7
Being fair to participants in placebo-controlled COVID-19 vaccine trials.
Nat Med. 2021 Jun;27(6):938. doi: 10.1038/s41591-021-01338-1.
8
India's COVID-vaccine woes - by the numbers.
Nature. 2021 Apr;592(7855):500-501. doi: 10.1038/d41586-021-00996-y.
9
Africa needs more genome sequencing to tackle new variants of SARS-CoV-2.
Nat Med. 2021 May;27(5):744-745. doi: 10.1038/s41591-021-01327-4.
10
Emerging concerns regarding COVID-19; second wave and new variant.
J Med Virol. 2021 Jul;93(7):4108-4110. doi: 10.1002/jmv.26979. Epub 2021 Apr 14.

引用本文的文献

1
A new laser device for ultra-rapid and sustainable aerosol sterilization.
Environ Int. 2022 Jun;164:107272. doi: 10.1016/j.envint.2022.107272. Epub 2022 May 2.

本文引用的文献

2
COVID-19 vaccines: what do we know so far?
FEBS J. 2021 Sep;288(17):4996-5009. doi: 10.1111/febs.16094. Epub 2021 Jul 19.
3
Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
FEBS J. 2021 Sep;288(17):5163-5178. doi: 10.1111/febs.16114. Epub 2021 Jul 29.
4
The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.
FEBS J. 2021 Sep;288(17):5042-5054. doi: 10.1111/febs.16105. Epub 2021 Jul 31.
5
Infection-induced inflammation from specific inborn errors of immunity to COVID-19.
FEBS J. 2021 Sep;288(17):5021-5041. doi: 10.1111/febs.15961. Epub 2021 May 20.
6
Host PDZ-containing proteins targeted by SARS-CoV-2.
FEBS J. 2021 Sep;288(17):5148-5162. doi: 10.1111/febs.15881. Epub 2021 May 1.
9
Spotlight on COVID-19: from biology to therapy and prevention.
FEBS J. 2020 Sep;287(17):3606-3608. doi: 10.1111/febs.15530.
10
Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases.
FEBS J. 2021 Sep;288(17):5089-5121. doi: 10.1111/febs.15696. Epub 2021 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验